FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Paclitaxel Injection, USP
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

HQ Specialty Pharma (New 07/03/2019)

Company Contact Information:
201-857-8290

Presentation Posting Date Related Information
30 mg/5 mL (NDC 44567-504-1) 07/03/2019 Distributed by WG Critical Care. Discontinuance: no longer commercially viable
100 mg/16.7 mL (NDC 44567-505-1) 07/03/2019 Distributed by WG Critical Care. Discontinuance: no longer commercially viable
300 mg/50 mL (6 mg/mL)(NDC 44567-506-1) 07/03/2019 Distributed by WG Critical Care. Discontinuance: no longer commercially viable

Mylan Institutional (New 11/22/2019)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
100 mg in 16.7 mL (6 mg/mL), multi-dose vial (NDC 67457-449-17) 11/22/2019 December 2019

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English